Taxotere® (T) and doxorubicin (D) combination:: A phase II South American study in first line treatment (tt) of metastatic breast cancer (MBC)

被引：2
|
作者：
Vallejos, C
Nunez, P
Orlandi, L
Carranza, H
Fodor, M
Reyes, JM
Majlis, A
Gavilanes, P
Boussard, B
Salas, E
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81740-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1324
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [31] Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancer
    Nabholtz, JM
    Mackey, JR
    Smylie, M
    Paterson, A
    Noël, DR
    Al-Tweigeri, T
    Tonkin, K
    North, S
    Azli, N
    Riva, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 314 - 321
  • [32] A phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer (MBC): Interim safety results
    Brufsky, A. M.
    Hoelzer, K. L.
    Keaton, M. R.
    Beck, J. T.
    Krill-Jackson, E.
    Wang, Y.
    Hu, S.
    Vaughn, L. G.
    Shonukan, O. O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] Pilot study with pegylated liposomal doxorubicin (PLD) and docetaxel as first-line treatment in patients with metastatic breast cancer (MBC)
    Mel, J. R., Sr.
    Ramos, M.
    Cueva, J.
    Castellanos, J.
    Almanza, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] DOCETAXEL IN COMBINATION WITH NON PEGYLATED LIPOSOME-ENCAPSULATED DOXORUBICIN (MYOCET®) FOR THE TREATMENT OF METASTATIC BREAST CANCER (MBC) PATIENTS: A PHASE II CLINICAL STUDY
    Coltelli, L.
    Allegrini, G.
    Barletta, M. T.
    Giuntini, N.
    Safina, V.
    Barsanti, G.
    Bona, E.
    Di Marsico, R.
    Andreuccetti, M.
    Falcone, A.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 72 - 72
  • [35] Sequential treatment of docetaxel plus doxorubicin/cyclophosphamide (AC) as first-line chemotherapy for metastatic breast cancer (MBC).: Final results and survival analysis of a phase II study
    Antón, A
    Colomer, R
    Lluch, A
    Massuti, B
    Corral, M
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S68 - S69
  • [36] Sequential doxorubicin and docetaxel as first-line treatment in metastatic breast cancer:: a GEICAM-9801 phase II study
    Alba, E
    Ribelles, N
    Antón, A
    Pérez-Carrión, R
    López-Vega, JM
    Llanos, M
    Pelegri, A
    Florián, J
    Menéndez, M
    Godes, MJ
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 77 (01) : 1 - 8
  • [37] A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer
    Subramanyan, S
    Abeloff, MD
    Bond, SE
    Davidson, NE
    Fetting, JH
    Gordon, GB
    Kennedy, MJ
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (06) : 497 - 502
  • [38] Sequential Doxorubicin and Docetaxel as First-Line Treatment in Metastatic Breast Cancer: A GEICAM-9801 Phase II Study
    E. Alba
    N. Ribelles
    A. Antón
    R. Pérez-Carrión
    J.M. López-Vega
    M. Llanos
    A. Pelegri
    J. Florián
    M. Menéndez
    M.J. Godes
    [J]. Breast Cancer Research and Treatment, 2003, 77 : 1 - 8
  • [39] A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer
    Smitha Subramanyan
    Martin D. Abeloff
    Stephen E. Bond
    Nancy E. Davidson
    John H. Fetting
    Gary B. Gordon
    M. John Kennedy
    [J]. Cancer Chemotherapy and Pharmacology, 1999, 43 : 497 - 502
  • [40] Phase II study with dose finding of Oral Vinorelbine in combination with Capecitabine as first-line chemotherapy of Metastatic Breast Cancer (MBC): Preliminary results of the phase II part of the study
    不详
    [J]. EJC SUPPLEMENTS, 2006, 4 (02): : 167 - 167
12345